|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.820 CNY | -0.21% |
|
+3.21% | -12.84% |
| 05-25 | North China Pharma Gets China Nod for Kidney Anemia Drug | MT |
| 04-24 | North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 5.07 | 6.01 | 5.25 |
| Spread/Res. | -4.93% | -19.80% | -8.19% |
| Spread/Supp. | +3.88% | +14.76% | +14.76% |
| Support | 4.64 | 4.2 | 4.2 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 600812 Stock
- Charts North China Pharmaceutical Company.Ltd
Select your edition
All financial news and data tailored to specific country editions
